A 12-month follow-up study of patients with systemic lupus erythematosus after immunization against SARS-CoV-2.

Ernesto Zavala-Flores Jannin Salcedo-MatienzoRoberto Huamanchumo-GuzmanAlfredo Berrocal-KasayGraciela S Alarcon

Published in: Lupus (2024)

33 of 100 SLE patients immunized with BNT162b2 vaccine against SARS-CoV-2, presented SLE flares (47 episodes in total); 5 of these patients required in-hospital management and all fully recovered; 26 patients had SARS-CoV-2 infection; three required hospitalization, one died.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
systemic lupus erythematosus
peritoneal dialysis
healthcare
coronavirus disease
patient reported